EUVIMEDEUVIMED entdecken
Open Access

Modulating aging-associated phenotypes in keratinocytes using antisense oligonucleotides targeting glycogenes

Bhanubhong Prommalee, Chalermchai Pilapong

Nanotheranostics · 2026

DOI: 10.7150/ntno.135510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanotheranostics, 2026. Verfasst von Bhanubhong Prommalee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of BioMolecular Imaging, Molecular and Cellular Biology, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chia…. Hauptthemen laut MEDLINE: Keratinocytes, Oligonucleotides, Antisense, Cellular Senescence. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age-related keratinocyte dysfunction has been associated with altered glycosylation and dysregulated expression of several glycogenes, including St6gal1, St3gal2, and Man1a. Modulation of these aging-associated glycogenes may therefore represent a potential approach for investigating cellular aging phenotypes. In this study, an in vitro aging-like keratinocyte model exhibiting increased expression of aging-associated glycogenes was established. Antisense oligonucleotides (ASOs) targeting the upregulated glycogenes were designed and evaluated using different oligonucleotide chemistries and delivery systems. Target gene expression, lectin-based glycan profiles, Lgr6 expression, and wound closure were assessed following ASO treatment. Among the ASOs tested, phosphorodiamidate morpholino (PMO)-linked Man1a ASOs demonstrated greater suppression of Man1a mRNA than ASOs targeting St6gal1 or St3gal2. Delivery of PMO-Man1a ASOs using milk-derived nanovesicles (NV) was associated with the greatest reduction in Man1a mRNA levels compared with commercial transfection reagents. Although no significant changes were detected in ConA-reactive mannose-rich glycans, treatment was associated with an increased proportion of Lgr6+ cells and accelerated wound closure in aging-like keratinocytes. Overall, this study provides proof-of-concept evidence that NV-mediated delivery of glycogene-targeting ASOs can modulate selected aging-associated phenotypes in keratinocytes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratinocytesOligonucleotides, AntisenseCellular SenescenceHumansSialyltransferasesPhenotypeAnimalsbeta-D-Galactoside alpha 2-6-Sialyltransferasebeta-Galactoside alpha-2,3-Sialyltransferase

Stichwörter der Autor:innen

aging-like keratinocytesantisense oligonucleotidesglycogenemilk-derived nanovesicle

Substanzen

Oligonucleotides, AntisenseSialyltransferasesbeta-D-Galactoside alpha 2-6-Sialyltransferasebeta-Galactoside alpha-2,3-Sialyltransferase

Autor:innen und Institutionen

  • Laboratory of BioMolecular Imaging, Molecular and Cellular Biology, Department of Radiologic Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand.

Zitieren

APA

Prommalee, B., & Pilapong, C. (2026). Modulating aging-associated phenotypes in keratinocytes using antisense oligonucleotides targeting glycogenes. Nanotheranostics. https://doi.org/10.7150/ntno.135510

Vancouver

Prommalee B, Pilapong C. Modulating aging-associated phenotypes in keratinocytes using antisense oligonucleotides targeting glycogenes. Nanotheranostics. 2026. doi:10.7150/ntno.135510

BibTeX
@article{Prommalee2026,
  author = {Prommalee, Bhanubhong and Pilapong, Chalermchai},
  title = {Modulating aging-associated phenotypes in keratinocytes using antisense oligonucleotides targeting glycogenes},
  journal = {Nanotheranostics},
  year = {2026},
  doi = {10.7150/ntno.135510}
}
Kostenlos starten →